Health Problems

Protein mapping pinpoints why metastatic melanoma patients do not respond to immunotherapy

Tel Aviv University and Sheba Medical Center researchers say they have discovered why more than half of patients with metastatic melanoma do not respond to immunotherapy cancer treatments. Wielding proteomics, an innovative “protein mapping” approach, a team of researchers led by Prof. Tami Geiger, Prof. Gal Markel, and Dr. Michal Harel of TAU’s Sackler School […]

Health Problems

Adding immunotherapy after initial treatment can benefit metastatic lung cancer patients

Treating metastatic non-small cell lung cancer (NSCLC) patients with the immunotherapy drug pembrolizumab after they’ve completed locally ablative therapy—meaning all known sites of their cancer were either treated with surgery, radiation, or other definitive treatments—almost tripled the median progression-free survival (PFS) compared to the historical average. Research from the Abramson Cancer Center at the University […]